Erratum: Does memantine improve the gait of individuals with Alzheimer's disease? (Journal of the American Geriatrics Society (2011) 59 (2181-2182) (DOI: 10.1111/j.1532-5415.2011.03648.x);Does memantine improve the gait of individuals with Alzheimer's disease?

Journal of the American Geriatrics Society

Volumn 59, Issue 11, 2011, Pages 2181-2182

  Beauchet, Olivier ^a   Allali, Gilles ^b   Launay, Cyrille ^a   Fantino, Bruno ^a   Annweiler, Cédric ^a  

^a ANGERS UNIVERSITY HOSPITAL   (France)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

MEMANTINE;

AGED; ALZHEIMER DISEASE; BRAIN CORTEX; CLINICAL ARTICLE; CLINICAL EVALUATION; CORPUS STRIATUM; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG DOSE TITRATION; FEMALE; GAIT DISORDER; HUMAN; LETTER; MALE; NEUROTRANSMISSION; SCORING SYSTEM;

EID: 80655141347     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/jgs.12046     Document Type: Erratum

References (7)

1. McShane R, Areosa Sastre A, Minakaran N,. Memantine for dementia. Cochrane Database Syst Rev 2006; 2: CD003154.
2. Assal F, Allali G, Kressig RW, et al. Galantamine improves gait performance in patients with Alzheimer's disease. J Am Geriatr Soc 2008; 56: 946-947.
3. Beauchet O, Allali G, Annweiler C, et al. Gait variability among healthy adults: Low and high stride-to-stride variability are both a reflection of gait stability. Gerontology 2009; 55: 702-706.
4. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th Ed. Washington, DC: American Psychiatric Association, 1994.
5. Kressig RW, Beauchet O,. Guidelines for clinical applications of spatio-temporal gait analysis in older adults. Aging Clin Exp Res 2006; 18: 174-176.
6. Almeida QJ, Frank JS, Roy EA, et al. Dopaminergic modulation of timing control and variability in the gait of Parkinson's disease. Mov Disord 2007; 22: 1735-1742.
7. Parsons CG, Stöffler A, Danysz W,. Memantine: A NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system-too little activation is bad, too much is even worse. Neuropharmacology 2007; 53: 699-723.